Healthcare provider profile · identity verified

Christopher Michael Carroll, D.O.

Family Practice · CORNING, NY · NPI 1811378094

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	601	177
Lisinopril	Lisinopril	303	95
Pantoprazole Sodium	Pantoprazole Sodium	271	85
Amlodipine Besylate	Amlodipine Besylate	250	76
Tamsulosin Hcl	Tamsulosin Hcl	246	74
Levothyroxine Sodium	Levothyroxine Sodium	240	69
Metoprolol Succinate	Metoprolol Succinate	217	65
Metformin Hcl	Metformin Hcl	215	62
Losartan Potassium	Losartan Potassium	212	70
Omeprazole	Omeprazole	209	68
Gabapentin	Gabapentin	188	65
Rosuvastatin Calcium	Rosuvastatin Calcium	168	53
Albuterol Sulfate Hfa	Albuterol Sulfate	148	64
Hydrochlorothiazide	Hydrochlorothiazide	127	43
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	116	34
Ozempic	Semaglutide	115	28
Eliquis	Apixaban	107	30
Furosemide	Furosemide	106	48
Metformin Hcl Er	Metformin Hcl	105	34
Fluticasone Propionate	Fluticasone Propionate	101	41
Trulicity	Dulaglutide	99	22
Glipizide Er	Glipizide	96	26
Allopurinol	Allopurinol	94	31
Simvastatin	Simvastatin	94	26
Finasteride	Finasteride	91	30
Montelukast Sodium	Montelukast Sodium	91	19
Trazodone Hcl	Trazodone Hcl	91	25
Tramadol Hcl	Tramadol Hcl	82	45
Prednisone	Prednisone	79	59
Clonazepam	Clonazepam	75	22
Metoprolol Tartrate	Metoprolol Tartrate	71	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	70	23
Famotidine	Famotidine	67	23
Clopidogrel	Clopidogrel Bisulfate	61	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	59	22
Zolpidem Tartrate	Zolpidem Tartrate	59	22
Sertraline Hcl	Sertraline Hcl	56	17
Duloxetine Hcl	Duloxetine Hcl	55	19
Spironolactone	Spironolactone	55	17
Potassium Chloride	Potassium Chloride	53	14
Meloxicam	Meloxicam	52	19
Pravastatin Sodium	Pravastatin Sodium	52	15
Valsartan	Valsartan	52	14
Pregabalin	Pregabalin	50	12
Amitriptyline Hcl	Amitriptyline Hcl	48	14
Ezetimibe	Ezetimibe	48	21
Farxiga	Dapagliflozin Propanediol	47	16
Escitalopram Oxalate	Escitalopram Oxalate	46	16
Glimepiride	Glimepiride	43	12
Bupropion Xl	Bupropion Hcl	42	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	41	35
Hydroxyzine Hcl	Hydroxyzine Hcl	41	18
Pioglitazone Hcl	Pioglitazone Hcl	40	14
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	39	11
Carvedilol	Carvedilol	39	16
Alprazolam	Alprazolam	37	21
Azithromycin	Azithromycin	37	31
Fenofibrate	Fenofibrate Nanocrystallized	37	13
Mirtazapine	Mirtazapine	37	suppressed
Vascepa	Icosapent Ethyl	37	suppressed
Breo Ellipta	Fluticasone/Vilanterol	35	15
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	35	suppressed
Alendronate Sodium	Alendronate Sodium	33	suppressed
Buspirone Hcl	Buspirone Hcl	32	11
Tizanidine Hcl	Tizanidine Hcl	31	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	31	11
Olmesartan Medoxomil	Olmesartan Medoxomil	30	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	30	suppressed
Paroxetine Hcl	Paroxetine Hcl	29	suppressed
Synthroid	Levothyroxine Sodium	29	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	28	28
Breyna	Budesonide/Formoterol Fumarate	28	suppressed
Jardiance	Empagliflozin	28	12
Triamcinolone Acetonide	Triamcinolone Acetonide	28	21
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Diclofenac Sodium	Diclofenac Sodium	26	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	26	suppressed
Donepezil Hcl	Donepezil Hcl	25	suppressed
Fluconazole	Fluconazole	25	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	25	suppressed
Olanzapine	Olanzapine	25	suppressed
Lansoprazole	Lansoprazole	24	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	24	suppressed
Xarelto	Rivaroxaban	24	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Oxycodone Hcl	Oxycodone Hcl	23	11
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Aripiprazole	Aripiprazole	21	suppressed
Atenolol	Atenolol	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	21	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Rybelsus	Semaglutide	21	suppressed
Bumetanide	Bumetanide	20	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	20	20
Lidocaine	Lidocaine	20	suppressed
Lorazepam	Lorazepam	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	12
Memantine Hcl	Memantine Hcl	20	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	20	20
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Divalproex Sodium	Divalproex Sodium	19	suppressed
Glipizide	Glipizide	19	suppressed
Ibuprofen	Ibuprofen	19	11
Methocarbamol	Methocarbamol	19	15
Sucralfate	Sucralfate	18	11
Insulin Lispro Kwikpen U-100	Insulin Lispro	17	suppressed
Linzess	Linaclotide	17	suppressed
Ramipril	Ramipril	17	suppressed
Sildenafil Citrate	Sildenafil Citrate	17	suppressed
Telmisartan	Telmisartan	17	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	16	suppressed
Celecoxib	Celecoxib	16	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Incruse Ellipta	Umeclidinium Bromide	16	suppressed
Methylprednisolone	Methylprednisolone	16	15
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	15	suppressed
Nebivolol Hcl	Nebivolol Hcl	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	14
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Baclofen	Baclofen	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Topiramate	Topiramate	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Sotalol	Sotalol Hcl	12	suppressed
Terbinafine Hcl	Terbinafine Hcl	12	suppressed
Torsemide	Torsemide	12	suppressed
Trijardy Xr	Empaglifloz/Linaglip/Metformin	12	suppressed
Zaleplon	Zaleplon	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Clindamycin Hcl	Clindamycin Hcl	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Nystatin	Nystatin	11	suppressed
Repatha Sureclick	Evolocumab	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error